Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
A Phase 2 clinical trial update evaluating the combination of clofarabine and temsirolimus in older patients with relapsed or refractory acu…
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid Hemopathy [Phase 1, Phase 2]
An update on a Phase I/II trial evaluating an immune therapy given after allogeneic transplantation in patients with myeloid hematologic dis…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant [NA]
A completed clinical trial evaluated Thymoglobulin to prevent acute graft-versus-host disease in patients with acute myeloid leukemia or acu…
-
CLINICAL_TRIALS trial_result · 2015-03-12Clinical Trial Update: Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study of sirolimus in pediatric patients with relapsed or refractory acute leukemia or non-Hodgkin's lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Haploid Allogeneic Transplant Using the CliniMACS System [Phase 2]
A Phase 2 clinical trial evaluating haploid allogeneic transplantation using the CliniMACS System was terminated, with results posted in 201…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) [Phase 2]
Phase II clinical trial evaluating a combination of idarubicin, cytarabine, and vorinostat in high-risk myelodysplastic syndrome and acute m…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia [Phase 2]
Phase 2 study S0112 evaluated cytarabine plus daunorubicin in older patients with acute myeloid leukemia; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia [Phase 3]
A Phase 3 trial comparing busulfan to cyclophosphamide as conditioning before total-body irradiation and peripheral stem cell transplantatio…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2]
A Phase 2 trial evaluating the combination of cyclosporine, daunorubicin, and cytarabine in older patients with previously untreated acute m…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers [Phase 1]
First-in-human Phase 1 trial assessing safety, tolerability, and preliminary efficacy of an anti-CXCR4 antibody in acute myeloid leukemia an…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia
This clinical trial update reports on biomarkers associated with response to cytarabine in samples from older patients with acute myeloid le…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial S0117 evaluating gemtuzumab ozogamicin plus cytarabine for relapsed acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial update evaluating PSC-833 with daunorubicin and cytarabine in older patients with newly diagnosed acute myeloid leukemia. The …
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S9031-S9126-S9333-S9500-B Biomarker Expression in Patients With Acute Myeloid Leukemia
This SWOG trial studied biomarker expression in patients with acute myeloid leukemia and has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia
This clinical trial update notes the completion of the study evaluating bone marrow and blood samples from patients with acute myeloid leuke…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia
The S0106B trial, which studied bone marrow samples from women with acute myeloid leukemia, has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients [Phase 2]
A Phase II trial evaluating clofarabine in pediatric patients with acute myeloid leukemia has completed. The study was sponsored by Genzyme …
-
CLINICAL_TRIALS trial_result · 2015-02-26Clinical Trial Update: Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML) [Phase 3]
A Phase 3 study comparing Vidaza (azacitidine) with conventional care regimens in acute myeloid leukemia has completed. Results were posted …
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT [Phase 2]
Phase 2 clinical trial evaluating reduced intensity total body irradiation plus Thymoglobulin followed by allogeneic peripheral blood stem c…
-
CLINICAL_TRIALS trial_result · 2015-02-11Clinical Trial Update: A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies [Phase 1]
A Phase 1 pilot study evaluated co-infusing ex vivo expanded cord blood cells with an unmanipulated cord blood unit in patients undergoing c…
-
CLINICAL_TRIALS trial_result · 2015-02-11Clinical Trial Update: Pilot Study of Unrelated Cord Blood Transplantation [Phase 2]
Phase 2 pilot trial of unrelated cord blood transplantation sponsored by King's College Hospital NHS Trust has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients [Phase 2]
A Phase 2 safety and efficacy study of AS101 for elderly patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome has been suspende…
-
CLINICAL_TRIALS trial_result · 2015-02-06Clinical Trial Update: Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AML [Phase 1, Phase 2]
A combined Phase 1/Phase 2 study evaluating vorinostat, azacitidine, and gemtuzumab ozogamicin in older adults with relapsed or refractory a…
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: SCH 727965 in Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia (P04717AM2)(TERMINATED) [Phase 2]
Phase 2 trial of SCH 727965 in patients with acute myeloid leukemia and acute lymphoblastic leukemia was terminated.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML) [Phase 1]
Phase 1 trial evaluating IV plerixafor with mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia was terminated.